Trial
NCT01063010
Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
The Cooper Health System; Carolinas Medical Center
Condition
Septic Shock
Intervention
Bevacizumab
Why stopped
no participants enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-29